MarketResearchTrends

  Vascular Grafts Market The surging prevalence of cardiac diseases is likely to favor the market growth during the appraisal period. Vascular grafts are regarded as one of the most prominent prosthetics which are extensively used in vascular and cardiovascular surgeries due to their ability to improve vascular access. Market Research Future (MRFR) asserts that the global  vascular graft market  is likely to garner USD 4.14 billion, grabbing a  CAGR of 7.6%  during the forecast period. They are required to replace injured veins, blood vessels, and arteries and also substitute hard valves and vessels. Vascular grafts are introduced with the help of surgical reconstruction process. The grafts can be synthetic, semi-synthetic, or can be directly taken from the patients; body. Major Key Players: The prominent players operating in the global vascular graft market comprises Gore Medical (US), Cardinal Health (US), C. R. Bard (US), Terumo (Japan), LeMaitre Vascular (US...

  Digital X-rays Market Digital x-ray is associated with the benefits of improved image quality, ease of equipment handling, image throughput, and most importantly, the ability to provide real-time results due to which they have gained widespread adoption among healthcare institutions. Market Research Future (MRFR) has analyzed the global;  digital x-rays market  to be a growing market which is anticipated to showcase substantial growth over the forecast period. Demand for efficient diagnostic technologies coupled with expanding healthcare budget across the globe has significantly driven the digital x-rays market. Chronic diseases are spreading at an alarming rate due to changing lifestyle and dietary habits which induce substantial demand for effective diagnostic methods for proper treatment. Other factors include government initiatives towards the modernization of healthcare sector and rise in the global aging population. Advancements in digital x-ray techniques, detect...

  Intravenous Immunoglobulin Market Intravenous Immunoglobulin (IVIg), a compound comprising of immune proteins (globulins) is administered into the bloodstream to treat patients with inefficient or damaged immune systems. IVIg provides the required antibodies by the human body to fight out the immune deficiency, and the ensuing infectious attacks. The global  Intravenous Immunoglobulin (IVIg) market  has been evaluated as moderately growing market and it is expected that the market will continue to grow similarly in the near future. The demand for new products and therapy is growing continuously. The market for Intravenous Immunoglobulin (IVIg) was around US$ 5910.8 million in 2016 and is expected to grow at a  CAGR of 5.9%  during forecast. Immunodeficiency disorder could be a hereditary issue (Primary disorders), or caused due to the exposure to infections, mainly through bodily fluids, along with the cancer drugs and chemotherapy, aging is one of the key ris...

  Obesity Managements Market The global  obesity managements market  is growing with a swift phase; mainly due to increase in patient population and research and development done by market players to fill the gap of market. According to World Health Organization (WHO), the worldwide prevalence of obesity nearly doubled between 1980 and 2008. According to country estimates for 2008, over 50% of both men and women in the WHO European Region were overweight, and roughly 23% of women and 20% of men were obese. It is the cause of many health problems, such as obesity, heart disease, and certain cancers. Obesity leads to short- and long-term health problems for mother and her child, if she is excess weight during pregnancy. Companies are continuously engaged in research and development process along with well know research institute for developing the best treatment of obesity and leads the market. In 2015, researchers at the University of Liverpool, working with a global healt...

  Medical Nitrile Gloves Market The global  medical nitrile gloves market  is expected to have a market value of USD 5,897.81 million by 2027. Nitrile medical grade gloves are great for use in healthcare fields of any kind seeing as they protect against bodily fluids, blood borne pathogens and are highly puncture resistant. Increasing incidence of COVID-19,increasing demand and shortage of medical nitrile gloves, and the rising concerns about safety and sanitation is driving the market growth of this market. Major Key Players: Some of the key players operating in the  nitrile gloves manufacturers  are Dynarex Corporation (US)., Shield Scientific B.V. (Netherland), Mercator Medical S.A, (Poland), Hartalega Holdings Berhad (Malaysia),Top Glove Corporation Bhd (Malaysia), Kossan Rubber Industries Bhd (KRI) (Malaysia), Ansell Healthcare (US), Medline Industries, In (US), 3M (US), McKesson Corporation (US), Honeywell International Inc (US), Atrium Medical Care (...

  Body Composition Analyzers Market According to MRFR analysis,  Body Composition Analyzers Market   is expected to register a  CAGR of   7.6%  during the forecast period. Body composition contains three major compound water, fat mass, and muscle mass. Body composition analyzing devices are used for measuring the ratio of water, fat, and muscles in the body and recording their respective values at the point of the investigation. Body composition analyzers provide aid in analysis of increased variations in the body structure for a specific period. It has applications medical research, sports, causal association research studies in the disciplines of nutrition, anthropology, epidemiology, etc. The growth of the global body composition analyzers market is determined by numerous factors such as increasing prevalence of metabolic disorders, technological advancements in the healthcare industry, and rising obese population. However, the increasing cost of body co...

  Radiology Services Market The Global  Radiology Services Market  is accounted for USD 8,102.51 million in 2018 and expected to register 10.5% CAGR during the forecast period. The radiology services refer to an expert consultant treating disease by choosing the proper examination, interpreting the resulting medical images, and using test results in monitoring the operations of medical care, treating diseases by using radiation or minimally invasive, image-guided therapeutic arbitration. The increasing healthcare expenditure, prevalence of the chronic disease, technology advancement, the emergence of thin client 3D viewers, increasing demand for minimally invasive procedures are the factor driving the growth of the market. Moreover, rising spending on research and development and aggressive strategies adopted by the top players, such as new product launches, are contributing to the growth of the market .  For instance, according to a research paper published by the N...

  Animal Vaccines Market The global  animal vaccines market  is expected to have a market value of USD 13,209.14 million by 2027. The animal vaccines market suffered immensely because pet owners and farmers were encouraged to keep their animals at home. They were advised against taking their pets to the vet to get strong and effective vaccines like the Pfizer veterinary vaccines. Growth in the veterinary/animal vaccines market is starting to pick up dramatically now that a vaccine for COVID-19 is being widely administered. Demand for animal vaccines is surging because livestock on farms around the world need these to remain healthy. Major Key Players: Some of the key players operating in the animal vaccines market are Boehringer Ingelheim International GmbH (Germany), Zoetis Inc. (US), Ceva Santé Animale (France), Merck & Co., Inc. (US), Elanco Animal Health Incorporated (US), Virbac (France), Phibro Animal Health Corporation (US), Hipra (Spain), Biogénesis Bagó S.A.(...

  Biobanking Market Biobanking Market  will grow at CAGR of 6.4% to hit $ 70,250.55 Million by 2030 Factors such as the increasing prevalence of chronic diseases and rising therapeutics demand are estimated to drive the market growth during the forecast period. Additionally, advancements in diagnostic and treatment technologies boost the market. However, low awareness and lack of healthcare services in the middle and low-income countries are estimated to restrain the market growth during the projected period. Major Key Players: Some of the key players in this market are Hamilton Company, Greiner Holding AG, Promega Corporation, Becton Dickinson and Company, Merck KGaA, VWR Corporation, Tecan Trading AG, Thermo Fisher Scientific Inc., Panasonic Healthcare Holdings Co., Ltd, Qiagen N.V., Brooks Automation, Inc., Chart Industries, Inc., and others. Segment Analysis The global biobanking market is segmented on the basis of products and services, sample type, storage type, applicat...

  Fertility Services Market Global  Fertility Services Market  is expected to register a CAGR of 6.02% during the forecast period and hit USD 37,357.51 Million by 2027. Fertility services are procedures or treatments incorporated to cure genetic and fertility issues and assist in conception. These services include Assisted Reproductive Technology (ART) methods and drugs that help single parents, infertile couples, and the Lesbian, Gay, Bisexual, and Transgender (LGBT) community in planning a family. The declining fertility rate, technological advancements in fertility treatments, growth in the median age of first-time motherhood, and rise in obesity and the consumption of alcohol/cigarettes lead to infertility, which is eventually driving the market for fertility services. According to ESHRE, more than 25 million European Union (EU) citizens are affected by infertility. In France, reimbursement/state funding includes six IUI’s (one IUI per menstruation cycl...

  Oligonucleotide Synthesis Market The global  oligonucleotide synthesis market , as per the reports of Market Research Future (MRFR) is all set to rise by 10.3% CAGR during the forecast period. The market over the review period is also expected to earn substantial valuation. The chemical synthesis of the nucleic acids with definite chemical structures is known as oligonucleotide synthesis. Its ability to produce results regarding customized nucleotides rapidly through inexpensive methods is making it choicest preference for a lot of research laboratories that are spending heavily in developing biotechnologies. The desired oligonucleotide requires a perfect oligonucleotide chain which can easily be made in laboratories. The completion of the chain sees a release from the solid phase to the solution, deprotected, and collected. MRFR in their recent report on the oligonucleotide synthesis market distinctly studied segments with their proper valuation both value-wise and volume-w...

  AI in Drug Discovery Market The growth of the global AI in drug discovery market is driven by various factors such as investments by industry giants into the AI business, increasing number of startups operating in AI spectrum for healthcare including drug discovery, machine learning, and other AI technologies and increased use of AI technology by major pharma companies in the drug discovery. According to MRFR analysis, the Global  AI in Drug Discovery Market   is expected to register a  CAGR of 40.8%  during the forecast period and is anticipated to reach  USD 2,015.1 Million by 2025. In addition, the increasing number of cross-industry partnerships for achieving the common goal of improvement in the drug development outcomes is another factor for the growth of the AI in the drug discovery market. Below is the chart representing the number of AI-driven deals each of the Big Biopharma companies have disclosed till March 2019. Major Key Players: Player...

  Gene Therapy Market Gene therapy is a technique in which a piece of DNA is incorporated into the cell via a vector. The key players are investing in the manufacturing of cell and gene therapy treatments due to its target specificity. The gene therapy is mainly of two types, somatic gene therapy, and germline gene therapy, depending on the type of cells its targets. According to MRFR analysis, the global gene therapy market is expected to register a CAGR of 40.7% during the forecast period and was valued at USD 524 million in 2018. The growth of the global gene therapy market is attributed to various factors such as robust product pipeline, increasing investment by key players, and high prevalence of target diseases and demand for innovative medication. However, the high cost of product development and stringent regulatory policies are expected to curb the growth of the global gene therapy market. The global gene therapy market is currently dominated by several market...